The Beauty Health Company (SKIN)

NASDAQ: SKIN · IEX Real-Time Price · USD

1.960

+0.120 (6.52%)

At close: Jul 2, 2024, 4:00 PM

1.979

+0.019 (0.97%)

After-hours: Jul 2, 2024, 5:47 PM EDT

The Beauty Health Company Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-100.12	44.22	-378.76	-29.18	-1.64	Upgrade
Depreciation & Amortization	34.68	22.87	17.93	14.53	13.94	Upgrade
Share-Based Compensation	22.54	28.5	12.42	0.36	0.1	Upgrade
Other Operating Activities	64.65	-202.19	320.06	1.84	-10.68	Upgrade
Operating Cash Flow	21.75	-106.6	-28.36	-12.44	1.73	Upgrade
Capital Expenditures	-13.05	-17.39	-15.62	-3.82	-10.42	Upgrade
Acquisitions	-18.46	-1.48	-22.9	0	-2.06	Upgrade
Other Investing Activities	-	-	0.78	-	-	Upgrade
Investing Cash Flow	-31.51	-18.87	-37.73	-3.82	-12.48	Upgrade
Share Issuance / Repurchase	-32.4	-160	546.01	-0.15	-1.77	Upgrade
Debt Issued / Paid	0	0	413.02	19.65	16.35	Upgrade
Other Financing Activities	-5.05	-45.24	-	-1.22	-	Upgrade
Financing Cash Flow	-37.45	-205.24	959.04	18.27	14.58	Upgrade
Exchange Rate Effect	2.03	-2.98	-0.54	0.16	-0.09	Upgrade
Net Cash Flow	-47.21	-330.71	892.94	2.02	3.83	Upgrade
Free Cash Flow	8.7	-123.99	-43.98	-16.25	-8.69	Upgrade
Free Cash Flow Margin	2.19%	-33.89%	-16.91%	-13.65%	-5.22%	Upgrade
Free Cash Flow Per Share	0.07	-0.84	-0.43	-0.47	-0.27	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).